+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Lipid Nanoparticle Raw Materials Market Size, Share & Trends Analysis Report by Application (Therapeutics, Research), Product (Kits, Reagents), Disease Indication, End-use, Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 120 Pages
  • March 2024
  • Region: Global
  • Grand View Research
  • ID: 5950113
Description Jump to:
The global lipid nanoparticle raw materials market size is anticipated to reach USD 329.2 million by 2030 and it is projected to grow at a CAGR of 5.66% from 2024 to 2030. Rising demand for drug-delivery systems, advancements in healthcare technologies, and the increasing prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological disorder are expected to boost the market further. Government investment can have a significant impact on the lipid nanoparticle raw material market. As governments invest in research and development of new technologies, including lipid nanoparticles, the demand for raw materials used in their production can increase. For instance, in April 2022, Croda International Plc was awarded USD 20.8 million by the UK Government to increase the output of its plant in Leek that manufactures lipids used in COVID-19 vaccines.

Advancements in lipid nanoparticle (LNP) formulation techniques have led to the development of more efficient and stable lipid-based carriers for drug delivery. Techniques such as microfluidics, solvent evaporation, and self-assembly processes enable precise control over the size, morphology, and surface properties of LNP, enhancing their performance as drug delivery vehicles. Researchers have developed innovative encapsulation strategies to improve the loading capacity and release kinetics of active pharmaceutical ingredients in LNP. Techniques such as solid lipid nanoparticle (SLN) technology, nanoemulsions, and lipid-drug conjugation enable efficient encapsulation of hydrophobic and hydrophilic drugs, as well as nucleic acids like RNA and DNA, expanding the range of therapeutic molecules that can be delivered using LNP.

The development of COVID-19 vaccines utilizing LNP-based delivery systems for mRNA vaccines garnered significant attention and resources during the pandemic. This increased focus on vaccine delivery technologies has indirectly benefited the market by driving innovation and investment in LNP formulation and manufacturing capabilities. Regulatory agencies expedited the review and approval processes for COVID-19 therapeutics and vaccines, including those utilizing LNP technology. While this facilitated rapid market entry for COVID-19 treatments, it also underscored the need for streamlined regulatory pathways and standards for LNP -based products in other therapeutic areas, potentially shaping future regulatory frameworks and market dynamics.

The market faces several challenges, including Intellectual property rights related to LNP formulations, manufacturing processes, and raw material compositions can pose barriers to market entry for new entrants and limit competition. Navigating patent landscapes and securing licenses for proprietary technologies can be challenging for companies seeking to commercialize lipid nanoparticle-based products. Transitioning from laboratory-scale to commercial-scale production of lipid nanoparticle-based products presents challenges in maintaining product quality, optimizing production yields, and meeting demand. Scale-up challenges include process scalability, equipment validation, and supply chain logistics.

Lipid Nanoparticle Raw Materials Market Report Highlights

  • Based on application, the therapeutic segment led the market with the largest revenue share of 62.25% in 2023, owing to the increasing collaborations between research institutions and industry players for the drug development and growing government funding
  • Based on product, the kits segment held the largest market share in 2023. On the other hand, reagents are expected to grow at a significant CAGR during the forecast period
  • Based on disease indication, the infectious disease segment dominated the market and is expected to grow at the fastest CAGR during the forecast period
  • Based on end-use, the pharmaceutical & biotechnology companies segment led the market with the largest revenue share of 57.87% in 2023. The academic & research institute segment is expected to grow at a fastest CAGR during the forecast period
  • North America dominated the market with a revenue share of 40.34% in 2023, owing to factors such as the significant burden of infectious diseases, high purchasing power parity, government support for quality healthcare, and availability of reimbursement


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Application
1.2.2. Product
1.2.3. Disease Indication
1.2.4. End-use
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing Demand for Drug Delivery Systems
3.2.1.2. Rise in Pharmaceutical Research and Development
3.2.1.3. Increasing Focus on Nanotechnology
3.2.1.4. Government Support and Funding
3.2.2. Market Restraint Analysis
3.2.2.1. High Development Costs
3.2.2.2. Stringent Regulations Related to The Approval and Commercialization
3.3. Industry Analysis Tools
3.3.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
3.3.2. Porter's Five Forces Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Lipid Nanoparticle Raw Materials Market: Application Business Analysis
4.1. Segment Dashboard
4.2. Global Lipid Nanoparticle Raw Materials Movement Analysis
4.3. Global Lipid Nanoparticle Raw Materials Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
4.4. Therapeutics
4.4.1. Global Therapeutics Market, 2018 - 2030 (USD Million)
4.5. Research
4.5.1. Global Research Market, 2018 - 2030 (USD Million)
Chapter 5. Lipid Nanoparticle Raw Materials Market: Product Business Analysis
5.1. Segment Dashboard
5.2. Global Lipid Nanoparticle Raw Materials Movement Analysis
5.3. Global Lipid Nanoparticle Raw Materials Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
5.4. Kits
5.4.1. Global Kits Market, 2018 - 2030 (USD Million)
5.4.2. Ionizable Lipids
5.4.2.1. Global Ionizable Lipids Market, 2018 - 2030 (USD Million)
5.4.3. PEGylated Lipids
5.4.3.1. Global PEGylated Lipids Market, 2018 - 2030 (USD Million)
5.4.4. Sterol Lipids
5.4.4.1. Global Sterol Lipids Market, 2018 - 2030 (USD Million)
5.4.5. Neutral Phospholipids
5.4.5.1. Global Neutral Phospholipids Market, 2018 - 2030 (USD Million)
5.5. Reagents
5.5.1. Global Reagents Market, 2018 - 2030 (USD Million)
5.6. Other Raw Materials
5.6.1. Global Other Raw Materials Market, 2018 - 2030 (USD Million)
Chapter 6. Lipid Nanoparticle Raw Materials Market: Disease Indication Business Analysis
6.1. Segment Dashboard
6.2. Global Lipid Nanoparticle Raw Materials Movement Analysis
6.3. Global Lipid Nanoparticle Raw Materials Market Size & Trend Analysis, by Disease Indication, 2018 to 2030 (USD Million)
6.4. Cancer
6.4.1. Global Cancer Market, 2018 - 2030 (USD Million)
6.5. Infectious Diseases
6.5.1. Global Infectious Diseases Market, 2018 - 2030 (USD Million)
6.6. Blood Diseases
6.6.1. Global Blood Diseases Market, 2018 - 2030 (USD Million)
6.7. Others
6.7.1. Global Others Market, 2018 - 2030 (USD Million)
Chapter 7. Lipid Nanoparticle Raw Materials Market: End-use Business Analysis
7.1. Segment Dashboard
7.2. Global Lipid Nanoparticle Raw Materials Movement Analysis
7.3. Global Lipid Nanoparticle Raw Materials Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
7.4. Pharmaceutical & Biotechnology Companies
7.4.1. Global Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
7.5. Academic & Research Institutes
7.5.1. Global Academic & Research Institutes Market, 2018 - 2030 (USD Million)
7.6. Others
7.6.1. Global Others Market, 2018 - 2030 (USD Million)
Chapter 8. Lipid Nanoparticle Raw Materials Market: Regional Estimates & Trend Analysis by Application, Product, Disease Indication, & End-use
8.1. Regional Dashboard
8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
8.3. North America
8.3.1. North America Lipid Nanoparticle Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.2. U.S.
8.3.2.1. Key Country Dynamics
8.3.2.2. Competitive Scenario
8.3.2.3. Target Disease Prevalence
8.3.2.4. Regulatory Framework
8.3.2.5. U.S. Lipid Nanoparticle Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.3. Canada
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Target Disease Prevalence
8.3.3.4. Regulatory Framework
8.3.3.5. Canada Lipid Nanoparticle Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Europe
8.4.1. Europe Lipid Nanoparticle Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.2. UK
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Target Disease Prevalence
8.4.2.4. Regulatory Framework
8.4.2.5. UK Lipid Nanoparticle Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.3. Germany
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Target Disease Prevalence
8.4.3.4. Regulatory Framework
8.4.3.5. Germany Lipid Nanoparticle Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.4. France
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Target Disease Prevalence
8.4.4.4. Regulatory Framework
8.4.4.5. France Lipid Nanoparticle Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.5. Italy
8.4.5.1. Key Country Dynamics
8.4.5.2. Competitive Scenario
8.4.5.3. Target Disease Prevalence
8.4.5.4. Regulatory Framework
8.4.5.5. Italy Lipid Nanoparticle Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.6. Spain
8.4.6.1. Key Country Dynamics
8.4.6.2. Competitive Scenario
8.4.6.3. Target Disease Prevalence
8.4.6.4. Regulatory Framework
8.4.6.5. Spain Lipid Nanoparticle Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.7. Denmark
8.4.7.1. Key Country Dynamics
8.4.7.2. Competitive Scenario
8.4.7.3. Target Disease Prevalence
8.4.7.4. Regulatory Framework
8.4.7.5. Denmark Lipid Nanoparticle Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.8. Sweden
8.4.8.1. Key Country Dynamics
8.4.8.2. Competitive Scenario
8.4.8.3. Target Disease Prevalence
8.4.8.4. Regulatory Framework
8.4.8.5. Sweden Lipid Nanoparticle Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.9. Norway
8.4.9.1. Key Country Dynamics
8.4.9.2. Competitive Scenario
8.4.9.3. Target Disease Prevalence
8.4.9.4. Regulatory Framework
8.4.9.5. Norway Lipid Nanoparticle Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Asia Pacific
8.5.1. Asia Pacific Lipid Nanoparticle Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.2. Japan
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Target Disease Prevalence
8.5.2.4. Regulatory Framework
8.5.2.5. Japan Lipid Nanoparticle Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.3. China
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Target Disease Prevalence
8.5.3.4. Regulatory Framework
8.5.3.5. China Lipid Nanoparticle Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.4. India
8.5.4.1. Key Country Dynamics
8.5.4.2. Competitive Scenario
8.5.4.3. Target Disease Prevalence
8.5.4.4. Regulatory Framework
8.5.4.5. India Lipid Nanoparticle Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.5. Australia
8.5.5.1. Key Country Dynamics
8.5.5.2. Competitive Scenario
8.5.5.3. Target Disease Prevalence
8.5.5.4. Regulatory Framework
8.5.5.5. Australia Lipid Nanoparticle Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.6. Thailand
8.5.6.1. Key Country Dynamics
8.5.6.2. Competitive Scenario
8.5.6.3. Target Disease Prevalence
8.5.6.4. Regulatory Framework
8.5.6.5. Thailand Lipid Nanoparticle Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.7. South Korea
8.5.7.1. Key Country Dynamics
8.5.7.2. Competitive Scenario
8.5.7.3. Target Disease Prevalence
8.5.7.4. Regulatory Framework
8.5.7.5. South Korea Lipid Nanoparticle Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Latin America
8.6.1. Latin America Lipid Nanoparticle Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.2. Brazil
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Target Disease Prevalence
8.6.2.4. Regulatory Framework
8.6.2.5. Brazil Lipid Nanoparticle Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.3. Mexico
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Target Disease Prevalence
8.6.3.4. Regulatory Framework
8.6.3.5. Mexico Lipid Nanoparticle Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.4. Argentina
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. Target Disease Prevalence
8.6.4.4. Regulatory Framework
8.6.4.5. Argentina Lipid Nanoparticle Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7. MEA
8.7.1. MEA Lipid Nanoparticle Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7.2. South Africa
8.7.2.1. Key Country Dynamics
8.7.2.2. Competitive Scenario
8.7.2.3. Target Disease Prevalence
8.7.2.4. Regulatory Framework
8.7.2.5. South Africa Lipid Nanoparticle Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7.3. Saudi Arabia
8.7.3.1. Key Country Dynamics
8.7.3.2. Competitive Scenario
8.7.3.3. Target Disease Prevalence
8.7.3.4. Regulatory Framework
8.7.3.5. Saudi Arabia Lipid Nanoparticle Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7.4. UAE
8.7.4.1. Key Country Dynamics
8.7.4.2. Competitive Scenario
8.7.4.3. Target Disease Prevalence
8.7.4.4. Regulatory Framework
8.7.4.5. UAE Lipid Nanoparticle Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7.5. Kuwait
8.7.5.1. Key Country Dynamics
8.7.5.2. Competitive Scenario
8.7.5.3. Target Disease Prevalence
8.7.5.4. Regulatory Framework
8.7.5.5. Kuwait Lipid Nanoparticle Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Participant Categorization
9.1.1. Market Leaders
9.1.1.1. Market Position analysis, 2023
9.2. Company Profiles/Listing
9.2.1. Merck KGaA
9.2.1.1. Overview
9.2.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.2.1.3. Technology Benchmarking
9.2.1.4. Strategic Initiatives
9.2.2. Echelon Biosciences
9.2.2.1. Overview
9.2.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.2.2.3. Technology Benchmarking
9.2.2.4. Strategic Initiatives
9.2.3. BroadPharm
9.2.3.1. Overview
9.2.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.2.3.3. Technology Benchmarking
9.2.3.4. Strategic Initiatives
9.2.4. Avanti Polar Lipids
9.2.4.1. Overview
9.2.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.2.4.3. Technology Benchmarking
9.2.4.4. Strategic Initiatives
9.2.5. Tebubio
9.2.5.1. Overview
9.2.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.2.5.3. Technology Benchmarking
9.2.5.4. Strategic Initiatives
9.2.6. Creative Biolabs
9.2.6.1. Overview
9.2.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.2.6.3. Technology Benchmarking
9.2.6.4. Strategic Initiatives
9.2.7. CordenPharma International
9.2.7.1. Overview
9.2.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.2.7.3. Technology Benchmarking
9.2.7.4. Strategic Initiatives
9.2.8. Biopharma PEG Scientific Inc.
9.2.8.1. Overview
9.2.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.2.8.3. Technology Benchmarking
9.2.8.4. Strategic Initiatives
9.2.9. NOF AMERICA CORPORATION
9.2.9.1. Overview
9.2.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.2.9.3. Technology Benchmarking
9.2.9.4. Strategic Initiatives
9.2.10. Polysciences, Inc.
9.2.10.1. Overview
9.2.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.2.10.3. Technology Benchmarking
9.2.10.4. Strategic Initiatives
9.3. Strategy Mapping
9.3.1. Expansion
9.3.2. Acquisition
9.3.3. Collaborations
9.3.4. Product/service launch
9.3.5. Partnerships
9.3.6. Others
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global lipid nanoparticle raw materials market, by application, 2018 - 2030 (USD Million)
Table 4 Global lipid nanoparticle raw materials market, by product, 2018 - 2030 (USD Million)
Table 5 Global lipid nanoparticle raw materials market, by disease indication, 2018 - 2030 (USD Million)
Table 6 Global lipid nanoparticle raw materials market, by end-use, 2018 - 2030 (USD Million)
Table 7 Global lipid nanoparticle raw materials market, by region, 2018 - 2030 (USD Million)
Table 8 North America lipid nanoparticle raw materials market, by country, 2018 - 2030 (USD Million)
Table 9 North America lipid nanoparticle raw materials market, by application, 2018 - 2030 (USD Million)
Table 10 North America lipid nanoparticle raw materials market, by product, 2018 - 2030 (USD Million)
Table 11 North America lipid nanoparticle raw materials market, by disease indication, 2018 - 2030 (USD Million)
Table 12 North America lipid nanoparticle raw materials market, by end-use, 2018 - 2030 (USD Million)
Table 13 U.S. lipid nanoparticle raw materials market, by application, 2018 - 2030 (USD Million)
Table 14 U.S. lipid nanoparticle raw materials market, by product, 2018 - 2030 (USD Million)
Table 15 U.S. lipid nanoparticle raw materials market, by disease indication, 2018 - 2030 (USD Million)
Table 16 U.S. lipid nanoparticle raw materials market, by end-use, 2018 - 2030 (USD Million)
Table 17 Canada lipid nanoparticle raw materials market, by application, 2018 - 2030 (USD Million)
Table 18 Canada lipid nanoparticle raw materials market, by product, 2018 - 2030 (USD Million)
Table 19 Canada lipid nanoparticle raw materials market, by disease indication, 2018 - 2030 (USD Million)
Table 20 Canada lipid nanoparticle raw materials market, by end-use, 2018 - 2030 (USD Million)
Table 21 Europe lipid nanoparticle raw materials market, by country, 2018 - 2030 (USD Million)
Table 22 Europe lipid nanoparticle raw materials market, by application, 2018 - 2030 (USD Million)
Table 23 Europe lipid nanoparticle raw materials market, by product, 2018 - 2030 (USD Million)
Table 24 Europe lipid nanoparticle raw materials market, by disease indication, 2018 - 2030 (USD Million)
Table 25 Europe lipid nanoparticle raw materials market, by end-use, 2018 - 2030 (USD Million)
Table 26 UK lipid nanoparticle raw materials market, by application, 2018 - 2030 (USD Million)
Table 27 UK lipid nanoparticle raw materials market, by product, 2018 - 2030 (USD Million)
Table 28 UK lipid nanoparticle raw materials market, by disease indication, 2018 - 2030 (USD Million)
Table 29 UK lipid nanoparticle raw materials market, by end-use, 2018 - 2030 (USD Million)
Table 30 Germany lipid nanoparticle raw materials market, by application, 2018 - 2030 (USD Million)
Table 31 Germany lipid nanoparticle raw materials market, by product, 2018 - 2030 (USD Million)
Table 32 Germany lipid nanoparticle raw materials market, by disease indication, 2018 - 2030 (USD Million)
Table 33 Germany lipid nanoparticle raw materials market, by end-use, 2018 - 2030 (USD Million)
Table 34 France lipid nanoparticle raw materials market, by application, 2018 - 2030 (USD Million)
Table 35 France lipid nanoparticle raw materials market, by product, 2018 - 2030 (USD Million)
Table 36 France lipid nanoparticle raw materials market, by disease indication, 2018 - 2030 (USD Million)
Table 37 France lipid nanoparticle raw materials market, by end-use, 2018 - 2030 (USD Million)
Table 38 Italy lipid nanoparticle raw materials market, by application, 2018 - 2030 (USD Million)
Table 39 Italy lipid nanoparticle raw materials market, by product, 2018 - 2030 (USD Million)
Table 40 Italy lipid nanoparticle raw materials market, by disease indication, 2018 - 2030 (USD Million)
Table 41 Italy lipid nanoparticle raw materials market, by end-use, 2018 - 2030 (USD Million)
Table 42 Spain lipid nanoparticle raw materials market, by application, 2018 - 2030 (USD Million)
Table 43 Spain lipid nanoparticle raw materials market, by product, 2018 - 2030 (USD Million)
Table 44 Spain lipid nanoparticle raw materials market, by disease indication, 2018 - 2030 (USD Million)
Table 45 Spain lipid nanoparticle raw materials market, by end-use, 2018 - 2030 (USD Million)
Table 46 Denmark lipid nanoparticle raw materials market, by application, 2018 - 2030 (USD Million)
Table 47 Denmark lipid nanoparticle raw materials market, by product, 2018 - 2030 (USD Million)
Table 48 Denmark lipid nanoparticle raw materials market, by disease indication, 2018 - 2030 (USD Million)
Table 49 Denmark lipid nanoparticle raw materials market, by end-use, 2018 - 2030 (USD Million)
Table 50 Sweden lipid nanoparticle raw materials market, by application, 2018 - 2030 (USD Million)
Table 51 Sweden lipid nanoparticle raw materials market, by product, 2018 - 2030 (USD Million)
Table 52 Sweden lipid nanoparticle raw materials market, by disease indication, 2018 - 2030 (USD Million)
Table 53 Sweden lipid nanoparticle raw materials market, by end-use, 2018 - 2030 (USD Million)
Table 54 Norway lipid nanoparticle raw materials market, by application, 2018 - 2030 (USD Million)
Table 55 Norway lipid nanoparticle raw materials market, by product, 2018 - 2030 (USD Million)
Table 56 Norway lipid nanoparticle raw materials market, by disease indication, 2018 - 2030 (USD Million)
Table 57 Norway lipid nanoparticle raw materials market, by end-use, 2018 - 2030 (USD Million)
Table 58 Asia Pacific lipid nanoparticle raw materials market, by country, 2018 - 2030 (USD Million)
Table 59 Asia Pacific lipid nanoparticle raw materials market, by application, 2018 - 2030 (USD Million)
Table 60 Asia Pacific lipid nanoparticle raw materials market, by product, 2018 - 2030 (USD Million)
Table 61 Asia Pacific lipid nanoparticle raw materials market, by disease indication, 2018 - 2030 (USD Million)
Table 62 Asia Pacific lipid nanoparticle raw materials market, by end-use, 2018 - 2030 (USD Million)
Table 63 Japan lipid nanoparticle raw materials market, by application, 2018 - 2030 (USD Million)
Table 64 Japan lipid nanoparticle raw materials market, by product, 2018 - 2030 (USD Million)
Table 65 Japan lipid nanoparticle raw materials market, by disease indication, 2018 - 2030 (USD Million)
Table 66 Japan lipid nanoparticle raw materials market, by end-use, 2018 - 2030 (USD Million)
Table 67 China lipid nanoparticle raw materials market, by application, 2018 - 2030 (USD Million)
Table 68 China lipid nanoparticle raw materials market, by product, 2018 - 2030 (USD Million)
Table 69 China lipid nanoparticle raw materials market, by disease indication, 2018 - 2030 (USD Million)
Table 70 China lipid nanoparticle raw materials market, by end-use, 2018 - 2030 (USD Million)
Table 71 India lipid nanoparticle raw materials market, by application, 2018 - 2030 (USD Million)
Table 72 India lipid nanoparticle raw materials market, by product, 2018 - 2030 (USD Million)
Table 73 India lipid nanoparticle raw materials market, by disease indication, 2018 - 2030 (USD Million)
Table 74 India lipid nanoparticle raw materials market, by end-use, 2018 - 2030 (USD Million)
Table 75 Australia lipid nanoparticle raw materials market, by application, 2018 - 2030 (USD Million)
Table 76 Australia lipid nanoparticle raw materials market, by product, 2018 - 2030 (USD Million)
Table 77 Australia lipid nanoparticle raw materials market, by disease indication, 2018 - 2030 (USD Million)
Table 78 Australia lipid nanoparticle raw materials market, by end-use, 2018 - 2030 (USD Million)
Table 79 Thailand lipid nanoparticle raw materials market, by application, 2018 - 2030 (USD Million)
Table 80 Thailand lipid nanoparticle raw materials market, by product, 2018 - 2030 (USD Million)
Table 81 Thailand lipid nanoparticle raw materials market, by disease indication, 2018 - 2030 (USD Million)
Table 82 Thailand lipid nanoparticle raw materials market, by end-use, 2018 - 2030 (USD Million)
Table 83 South Korea lipid nanoparticle raw materials market, by application, 2018 - 2030 (USD Million)
Table 84 South Korea lipid nanoparticle raw materials market, by product, 2018 - 2030 (USD Million)
Table 85 South Korea lipid nanoparticle raw materials market, by disease indication, 2018 - 2030 (USD Million)
Table 86 South Korea lipid nanoparticle raw materials market, by end-use, 2018 - 2030 (USD Million)
Table 87 Latin America lipid nanoparticle raw materials market, by country, 2018 - 2030 (USD Million)
Table 88 Latin America lipid nanoparticle raw materials market, by application, 2018 - 2030 (USD Million)
Table 89 Latin America lipid nanoparticle raw materials market, by product, 2018 - 2030 (USD Million)
Table 90 Latin America lipid nanoparticle raw materials market, by disease indication, 2018 - 2030 (USD Million)
Table 91 Latin America lipid nanoparticle raw materials market, by end-use, 2018 - 2030 (USD Million)
Table 92 Brazil lipid nanoparticle raw materials market, by application, 2018 - 2030 (USD Million)
Table 93 Brazil lipid nanoparticle raw materials market, by product, 2018 - 2030 (USD Million)
Table 94 Brazil lipid nanoparticle raw materials market, by disease indication, 2018 - 2030 (USD Million)
Table 95 Brazil lipid nanoparticle raw materials market, by end-use, 2018 - 2030 (USD Million)
Table 96 Mexico lipid nanoparticle raw materials market, by application, 2018 - 2030 (USD Million)
Table 97 Mexico lipid nanoparticle raw materials market, by product, 2018 - 2030 (USD Million)
Table 98 Mexico lipid nanoparticle raw materials market, by disease indication, 2018 - 2030 (USD Million)
Table 99 Mexico lipid nanoparticle raw materials market, by end-use, 2018 - 2030 (USD Million)
Table 100 Argentina lipid nanoparticle raw materials market, by application, 2018 - 2030 (USD Million)
Table 101 Argentina lipid nanoparticle raw materials market, by product, 2018 - 2030 (USD Million)
Table 102 Argentina lipid nanoparticle raw materials market, by disease indication, 2018 - 2030 (USD Million)
Table 103 Argentina lipid nanoparticle raw materials market, by end-use, 2018 - 2030 (USD Million)
Table 104 Middle East & Africa lipid nanoparticle raw materials market, by country, 2018 - 2030 (USD Million)
Table 105 Middle East & Africa lipid nanoparticle raw materials market, by application, 2018 - 2030 (USD Million)
Table 106 Middle East & Africa lipid nanoparticle raw materials market, by product, 2018 - 2030 (USD Million)
Table 107 Middle East & Africa lipid nanoparticle raw materials market, by disease indication, 2018 - 2030 (USD Million)
Table 108 Middle East & Africa lipid nanoparticle raw materials market, by end-use, 2018 - 2030 (USD Million)
Table 109 South Africa lipid nanoparticle raw materials market, by application, 2018 - 2030 (USD Million)
Table 110 South Africa lipid nanoparticle raw materials market, by product, 2018 - 2030 (USD Million)
Table 111 South Africa lipid nanoparticle raw materials market, by disease indication, 2018 - 2030 (USD Million)
Table 112 South Africa lipid nanoparticle raw materials market, by end-use, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia lipid nanoparticle raw materials market, by application, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia lipid nanoparticle raw materials market, by product, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia lipid nanoparticle raw materials market, by disease indication, 2018 - 2030 (USD Million)
Table 116 Saudi Arabia lipid nanoparticle raw materials market, by end-use, 2018 - 2030 (USD Million)
Table 117 UAE lipid nanoparticle raw materials market, by application, 2018 - 2030 (USD Million)
Table 118 UAE lipid nanoparticle raw materials market, by product, 2018 - 2030 (USD Million)
Table 119 UAE lipid nanoparticle raw materials market, by disease indication, 2018 - 2030 (USD Million)
Table 120 UAE lipid nanoparticle raw materials market, by end-use, 2018 - 2030 (USD Million)
Table 121 Kuwait lipid nanoparticle raw materials market, by application, 2018 - 2030 (USD Million)
Table 122 Kuwait lipid nanoparticle raw materials market, by product, 2018 - 2030 (USD Million)
Table 123 Kuwait lipid nanoparticle raw materials market, by disease indication, 2018 - 2030 (USD Million)
Table 124 Kuwait lipid nanoparticle raw materials market, by end-use, 2018 - 2030 (USD Million)
Table 125 Participant's overview
Table 126 Financial performance
Table 127 Key companies undergoing expansions
Table 128 Key companies undergoing acquisitions
Table 129 Key companies undergoing collaborations
Table 130 Key companies launching new products/services
Table 131 Key companies undertaking other strategies
List of Figures
Fig. 1 Lipid nanoparticle raw materials market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market snapshot
Fig. 10 Segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Parent market outlook
Fig. 13 Related/ancillary market outlook
Fig. 14 Genomics - Industry value chain analysis
Fig. 15 Lipid nanoparticle raw materials market driver analysis
Fig. 16 Lipid nanoparticle raw materials market restraint analysis
Fig. 17 Lipid nanoparticle raw materials market: Porter's analysis
Fig. 18 Lipid nanoparticle raw materials market: Application outlook and key takeaways
Fig. 19 Lipid nanoparticle raw materials market: Application market share analysis, 2023-2030
Fig. 20 Global lipid nanoparticle raw materials, by therapeutics market, 2018 - 2030 (USD Million)
Fig. 21 Global lipid nanoparticle raw materials, by research market, 2018 - 2030 (USD Million)
Fig. 22 Lipid nanoparticle raw materials market: Product outlook and key takeaways
Fig. 23 Lipid nanoparticle raw materials market: Product market share analysis, 2023-2030
Fig. 24 Global lipid nanoparticle raw materials, by kits market, 2018 - 2030 (USD Million)
Fig. 25 Global lipid nanoparticle raw materials, by ionizable lipids market, 2018 - 2030 (USD Million)
Fig. 26 Global lipid nanoparticle raw materials, by PEGylated lipids market, 2018 - 2030 (USD Million)
Fig. 27 Global lipid nanoparticle raw materials, by sterol lipids market, 2018 - 2030 (USD Million)
Fig. 28 Global lipid nanoparticle raw materials, by neutral phospholipids market, 2018 - 2030 (USD Million)
Fig. 29 Lipid nanoparticle raw materials market: Diseases indication outlook and key takeaways
Fig. 30 Lipid nanoparticle raw materials market: Diseases indication market share analysis, 2023-2030
Fig. 31 Global lipid nanoparticle raw materials, by cancer market, 2018 - 2030 (USD Million)
Fig. 32 Global lipid nanoparticle raw materials, by infectious diseases market, 2018 - 2030 (USD Million)
Fig. 33 Global lipid nanoparticle raw materials, by blood diseases market, 2018 - 2030 (USD Million)
Fig. 34 Global lipid nanoparticle raw materials, by others market, 2018 - 2030 (USD Million)
Fig. 35 Lipid nanoparticle raw materials market: End-use outlook and key takeaways
Fig. 36 Lipid nanoparticle raw materials market: end-use market share analysis, 2023 - 2030
Fig. 37 Global lipid nanoparticle raw materials, by pharmaceutical & biotechnology companies market, 2018 - 2030 (USD Million)
Fig. 38 Global lipid nanoparticle raw materials, by academic & research institutes market, 2018 - 2030 (USD Million)
Fig. 39 Global lipid nanoparticle raw materials, by others market, 2018 - 2030 (USD Million)
Fig. 40 Regional marketplace: Key takeaways
Fig. 41 Regional marketplace: Key takeaways
Fig. 42 North America lipid nanoparticle raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 U.S. key country dynamics
Fig. 44 U.S. lipid nanoparticle raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Canada key country dynamics
Fig. 46 Canada lipid nanoparticle raw materials market, 2018 - 2030 (USD Million)
Fig. 47 Europe lipid nanoparticle raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 UK key country dynamics
Fig. 49 UK lipid nanoparticle raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Germany key country dynamics
Fig. 51 Germany lipid nanoparticle raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 France key country dynamics
Fig. 53 France lipid nanoparticle raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Italy key country dynamics
Fig. 55 Italy lipid nanoparticle raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Spain key country dynamics
Fig. 57 Spain lipid nanoparticle raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 58 Denmark key country dynamics
Fig. 59 Denmark lipid nanoparticle raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 60 Sweden key country dynamics
Fig. 61 Sweden lipid nanoparticle raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 62 Norway key country dynamics
Fig. 63 Norway lipid nanoparticle raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 64 Asia-Pacific lipid nanoparticle raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 65 Japan key country dynamics
Fig. 66 Japan lipid nanoparticle raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 67 China key country dynamics
Fig. 68 China lipid nanoparticle raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 69 India key country dynamics
Fig. 70 India lipid nanoparticle raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 71 Australia key country dynamics
Fig. 72 Australia lipid nanoparticle raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 73 Thailand key country dynamics
Fig. 74 Thailand lipid nanoparticle raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 75 South Korea key country dynamics
Fig. 76 South Korea lipid nanoparticle raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 77 Latin America lipid nanoparticle raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 78 Brazil key country dynamics
Fig. 79 Brazil lipid nanoparticle raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 80 Mexico key country dynamics
Fig. 81 Mexico lipid nanoparticle raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 82 Argentina key country dynamics
Fig. 83 Argentina lipid nanoparticle raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 84 MEA lipid nanoparticle raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 85 South Africa key country dynamics
Fig. 86 South Africa lipid nanoparticle raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 87 Saudi Arabia key country dynamics
Fig. 88 Saudi Arabia lipid nanoparticle raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 89 UAE key country dynamics
Fig. 90 UAE lipid nanoparticle raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 91 Kuwait key country dynamics
Fig. 92 Kuwait lipid nanoparticle raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 93 Key company categorization
Fig. 94 Company market positioning
Fig. 95 Market participant categorization
Fig. 96 Strategy framework

Companies Mentioned

  • Merck KGaA
  • Echelon Biosciences
  • BroadPharm
  • Avanti Polar Lipids
  • Tebubio
  • Creative Biolabs
  • CordenPharma International
  • Biopharma PEG Scientific Inc.
  • NOF AMERICA CORPORATION
  • Polysciences, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages120
PublishedMarch 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 224.5 Million
Forecasted Market Value ( USD ) by 2030 $ 329.2 Million
Compound Annual Growth Rate5.6%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Global Lipid Nanoparticle Manufacturing Market 2023-2035: Services and Technologies - Distribution by Type of Lipid Nanoparticle, Type of Molecule Delivered, Company Size, Target Therapeutic Area, Type of End-user and Key Geographical Regions - Product Image

Global Lipid Nanoparticle Manufacturing Market 2023-2035: Services and Technologies - Distribution by Type of Lipid Nanoparticle, Type of Molecule Delivered, Company Size, Target Therapeutic Area, Type of End-user and Key Geographical Regions

  • Report
  • 290 Pages
  • Global
From
Global Lipid Nanoparticles Market Analysis & Forecast 2024-2034: Market By Type; By Application; By End-user; and By Region - Product Image

Global Lipid Nanoparticles Market Analysis & Forecast 2024-2034: Market By Type; By Application; By End-user; and By Region

  • Report
  • 145 Pages
  • Global
From
Nanoparticle Formulation Market - By Type of Nanoparticle (Organic (Polymeric, Lipid Nanoparticles, Viral & Others), Inorganic Nanoparticles and Carbon-based Nanoparticles), Scale of Operation and Key Geographies: Industry Trends and Global Forecasts, 2023-2035 - Product Image

Nanoparticle Formulation Market - By Type of Nanoparticle (Organic (Polymeric, Lipid Nanoparticles, Viral & Others), Inorganic Nanoparticles and Carbon-based Nanoparticles), Scale of Operation and Key Geographies: Industry Trends and Global Forecasts, 2023-2035

  • Report
  • 246 Pages
  • Global
From
Global Nanotechnology Drug Delivery Market Size, Share & Trends Analysis Report By Formulation (Polymer-Based Nanomedicine, Lipid-Based Nanomedicine, Nanocrystals, and Others), By Application, By Regional Outlook and Forecast, 2023 - 2030 - Product Image

Global Nanotechnology Drug Delivery Market Size, Share & Trends Analysis Report By Formulation (Polymer-Based Nanomedicine, Lipid-Based Nanomedicine, Nanocrystals, and Others), By Application, By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • Global
From
Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems - Product Image

Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems

  • Report
  • 174 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.